Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 708

1.

Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trial.

Shaw AT, Solomon BJ, Chiari R, Riely GJ, Besse B, Soo RA, Kao S, Lin CC, Bauer TM, Clancy JS, Thurm H, Martini JF, Peltz G, Abbattista A, Li S, Ou SI.

Lancet Oncol. 2019 Oct 25. pii: S1470-2045(19)30655-2. doi: 10.1016/S1470-2045(19)30655-2. [Epub ahead of print]

PMID:
31669155
2.

Australian consensus statement for best practice ROS1 testing in advanced non-small cell lung cancer.

Pavlakis N, Cooper C, John T, Kao S, Klebe S, Lee CK, Leong T, Millward M, O'Byrne K, Russell PA, Solomon B, Cooper WA, Fox S.

Pathology. 2019 Dec;51(7):673-680. doi: 10.1016/j.pathol.2019.08.006. Epub 2019 Oct 24.

PMID:
31668406
3.

First-in-human phase I clinical trial of a combined immune modulatory approach using TetMYB vaccine and Anti-PD-1 antibody in patients with advanced solid cancer including colorectal or adenoid cystic carcinoma: The MYPHISMO study protocol (NCT03287427).

Pham T, Pereira L, Roth S, Galletta L, Link E, Akhurst T, Solomon B, Michael M, Darcy P, Sampurno S, Heriot A, Ramsay R, Desai J.

Contemp Clin Trials Commun. 2019 Jul 10;16:100409. doi: 10.1016/j.conctc.2019.100409. eCollection 2019 Dec.

4.

Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol.

Iravani A, Solomon B, Pattison DA, Jackson P, Ravi Kumar A, Kong G, Hofman MS, Akhurst T, Hicks RJ.

Thyroid. 2019 Nov;29(11):1634-1645. doi: 10.1089/thy.2019.0143.

PMID:
31637953
5.

Medical-Financial Partnerships: Cross-Sector Collaborations Between Medical and Financial Services to Improve Health.

Bell ON, Hole MK, Johnson K, Marcil LE, Solomon BS, Schickedanz A.

Acad Pediatr. 2019 Oct 13. pii: S1876-2859(19)30427-9. doi: 10.1016/j.acap.2019.10.001. [Epub ahead of print] Review.

PMID:
31618676
6.

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.

Burr ML, Sparbier CE, Chan KL, Chan YC, Kersbergen A, Lam EYN, Azidis-Yates E, Vassiliadis D, Bell CC, Gilan O, Jackson S, Tan L, Wong SQ, Hollizeck S, Michalak EM, Siddle HV, McCabe MT, Prinjha RK, Guerra GR, Solomon BJ, Sandhu S, Dawson SJ, Beavis PA, Tothill RW, Cullinane C, Lehner PJ, Sutherland KD, Dawson MA.

Cancer Cell. 2019 Oct 14;36(4):385-401.e8. doi: 10.1016/j.ccell.2019.08.008. Epub 2019 Sep 26.

7.

Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103+ immune cell abundance.

Solomon B, Young RJ, Bressel M, Cernelc J, Savas P, Liu H, Urban D, Thai A, Cooper C, Fua T, Neeson P, Loi S, Porceddu SV, Rischin D.

Ann Oncol. 2019 Oct 1;30(10):1638-1646. doi: 10.1093/annonc/mdz271.

PMID:
31400196
8.

The Impact of State Firearm Laws on Homicide Rates in Suburban and Rural Areas Compared to Large Cities in the United States, 1991-2016.

Siegel M, Solomon B, Knopov A, Rothman EF, Cronin SW, Xuan Z, Hemenway D.

J Rural Health. 2019 Jul 30. doi: 10.1111/jrh.12387. [Epub ahead of print]

PMID:
31361355
9.

Targeting ROS1 Rearrangements in Non-small Cell Lung Cancer: Crizotinib and Newer Generation Tyrosine Kinase Inhibitors.

Morris TA, Khoo C, Solomon BJ.

Drugs. 2019 Aug;79(12):1277-1286. doi: 10.1007/s40265-019-01164-3. Review.

PMID:
31313100
10.

Disclosure of Infant Unsafe Sleep Practices by African American Mothers in Primary Care Settings.

Mahoney P, Solomon BS, McDonald EM, Shields WC, Gielen AC.

JAMA Pediatr. 2019 Jul 1. doi: 10.1001/jamapediatrics.2019.1687. [Epub ahead of print] No abstract available.

PMID:
31260002
11.

Five-parameter evaluation of dysphagia: A novel prognostic scale for assessing neurological decline in Gaucher disease type 2.

Seehra G, Solomon B, Ryan E, Steward AM, Roshan Lal T, Tanima Y, Lopez G, Sidransky E.

Mol Genet Metab. 2019 Jul;127(3):191-199. doi: 10.1016/j.ymgme.2019.06.002. Epub 2019 Jun 8.

PMID:
31256856
12.

Content of Infant Safe Sleep Counseling and Maternal Reported Practices in an Urban Clinic.

Burrell TD, McDonald EM, Mahoney P, Musci RJ, Shields W, Gielen A, Solomon BS.

Acad Pediatr. 2019 Sep - Oct;19(7):801-807. doi: 10.1016/j.acap.2019.06.014. Epub 2019 Jun 26.

PMID:
31254631
13.

Growth under intervention by means of instructional time expended: Empirical illustrations of applicable models.

Solomon BG, Poncy BC.

Sch Psychol. 2019 Sep;34(5):566-575. doi: 10.1037/spq0000327. Epub 2019 Jun 27.

PMID:
31246062
14.

Supercharging adoptive T cell therapy to overcome solid tumor-induced immunosuppression.

Mardiana S, Solomon BJ, Darcy PK, Beavis PA.

Sci Transl Med. 2019 Jun 5;11(495). pii: eaaw2293. doi: 10.1126/scitranslmed.aaw2293. Review.

PMID:
31167925
15.

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.

Mazières J, Drilon A, Lusque A, Mhanna L, Cortot AB, Mezquita L, Thai AA, Mascaux C, Couraud S, Veillon R, Van Den Heuvel M, Neal J, Peled N, Früh M, Ng TL, Gounant V, Popat S, Diebold J, Sabari J, Zhu VW, Rothschild SI, Bironzo P, Martinez A, Curioni-Fontecedro A, Rosell R, Lattuca-Truc M, Wiesweg M, Besse B, Solomon B, Barlesi F, Schouten RD, Wakelee H, Camidge DR, Zalcman G, Novello S, Ou SI, Milia J, Gautschi O.

Ann Oncol. 2019 May 24. pii: mdz167. doi: 10.1093/annonc/mdz167. [Epub ahead of print]

PMID:
31125062
16.

Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.

Rivalland G, Mitchell P, Murone C, Asadi K, Morey AL, Starmans M, Boutros PC, Walkiewicz M, Solomon B, Wright G, Knight S, John T.

Transl Lung Cancer Res. 2019 Apr;8(2):167-175. doi: 10.21037/tlcr.2019.03.11.

17.

Mobility of Yield Stress Fluids on Lubricant-Impregnated Surfaces.

Rapoport L, Solomon BR, Varanasi KK.

ACS Appl Mater Interfaces. 2019 May 1;11(17):16123-16129. doi: 10.1021/acsami.8b21478. Epub 2019 Apr 22.

PMID:
31008574
18.

Advanced-Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018.

Remon J, Ahn MJ, Girard N, Johnson M, Kim DW, Lopes G, Pillai RN, Solomon B, Villacampa G, Zhou Q.

J Thorac Oncol. 2019 Jul;14(7):1134-1155. doi: 10.1016/j.jtho.2019.03.022. Epub 2019 Apr 16. Review.

PMID:
31002952
19.

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.

Shaw AT, Riely GJ, Bang YJ, Kim DW, Camidge DR, Solomon BJ, Varella-Garcia M, Iafrate AJ, Shapiro GI, Usari T, Wang SC, Wilner KD, Clark JW, Ou SI.

Ann Oncol. 2019 Jul 1;30(7):1121-1126. doi: 10.1093/annonc/mdz131.

20.

Clinical exome sequencing in 509 Middle Eastern families with suspected Mendelian diseases: The Qatari experience.

Al-Dewik N, Mohd H, Al-Mureikhi M, Ali R, Al-Mesaifri F, Mahmoud L, Shahbeck N, El-Akouri K, Almulla M, Al Sulaiman R, Musa S, Al-Marri AA, Richard G, Juusola J, Solomon BD, Alkuraya FS, Ben-Omran T.

Am J Med Genet A. 2019 Jun;179(6):927-935. doi: 10.1002/ajmg.a.61126. Epub 2019 Mar 27.

PMID:
30919572
21.

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors.

Hellmann MD, Kim TW, Lee CB, Goh BC, Miller WH, Oh DY, Jamal R, Chee CE, Chow LQM, Gainor JF, Desai J, Solomon BJ, Das Thakur M, Pitcher B, Foster P, Hernandez G, Wongchenko MJ, Cha E, Bang YJ, Siu LL, Bendell J.

Ann Oncol. 2019 Jul 1;30(7):1134-1142. doi: 10.1093/annonc/mdz113.

PMID:
30918950
22.

ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer.

Shaw AT, Solomon BJ, Besse B, Bauer TM, Lin CC, Soo RA, Riely GJ, Ou SI, Clancy JS, Li S, Abbattista A, Thurm H, Satouchi M, Camidge DR, Kao S, Chiari R, Gadgeel SM, Felip E, Martini JF.

J Clin Oncol. 2019 Jun 1;37(16):1370-1379. doi: 10.1200/JCO.18.02236. Epub 2019 Mar 20.

PMID:
30892989
23.

Clinical Management of Adverse Events Associated with Lorlatinib.

Bauer TM, Felip E, Solomon BJ, Thurm H, Peltz G, Chioda MD, Shaw AT.

Oncologist. 2019 Aug;24(8):1103-1110. doi: 10.1634/theoncologist.2018-0380. Epub 2019 Mar 19.

PMID:
30890623
24.

Genomic and molecular characterization of preterm birth.

Knijnenburg TA, Vockley JG, Chambwe N, Gibbs DL, Humphries C, Huddleston KC, Klein E, Kothiyal P, Tasseff R, Dhankani V, Bodian DL, Wong WSW, Glusman G, Mauldin DE, Miller M, Slagel J, Elasady S, Roach JC, Kramer R, Leinonen K, Linthorst J, Baveja R, Baker R, Solomon BD, Eley G, Iyer RK, Maxwell GL, Bernard B, Shmulevich I, Hood L, Niederhuber JE.

Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5819-5827. doi: 10.1073/pnas.1716314116. Epub 2019 Mar 4.

25.

Response to Wang et al.

Roberts ME, Zeinomar N, Solomon BD, Terry MB, Chung WK.

Genet Med. 2019 Sep;21(9):2158. doi: 10.1038/s41436-019-0469-2. Epub 2019 Mar 1. No abstract available.

PMID:
30824819
26.

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B; TROG 09.02 CHISEL investigators.

Lancet Oncol. 2019 Apr;20(4):494-503. doi: 10.1016/S1470-2045(18)30896-9. Epub 2019 Feb 12.

PMID:
30770291
27.

The Other Parent: An Exploratory Survey of Providers' Engagement of Fathers in Pediatric Primary Care.

Allport BS, Solomon BS, Johnson SB.

Clin Pediatr (Phila). 2019 May;58(5):555-563. doi: 10.1177/0009922819829032. Epub 2019 Feb 14.

PMID:
30762423
28.

Synthetic Butterfly Scale Surfaces with Compliance-Tailored Anisotropic Drop Adhesion.

Zhao H, Park SJ, Solomon BR, Kim S, Soto D, Paxson AT, Varanasi KK, Hart AJ.

Adv Mater. 2019 Apr;31(14):e1807686. doi: 10.1002/adma.201807686. Epub 2019 Feb 13.

PMID:
30761627
29.

Variants in TCF20 in neurodevelopmental disability: description of 27 new patients and review of literature.

Torti E, Keren B, Palmer EE, Zhu Z, Afenjar A, Anderson IJ, Andrews MV, Atkinson C, Au M, Berry SA, Bowling KM, Boyle J, Buratti J, Cathey SS, Charles P, Cogne B, Courtin T, Escobar LF, Finley SL, Graham JM Jr, Grange DK, Heron D, Hewson S, Hiatt SM, Hibbs KA, Jayakar P, Kalsner L, Larcher L, Lesca G, Mark PR, Miller K, Nava C, Nizon M, Pai GS, Pappas J, Parsons G, Payne K, Putoux A, Rabin R, Sabatier I, Shinawi M, Shur N, Skinner SA, Valence S, Warren H, Whalen S, Crunk A, Douglas G, Monaghan KG, Person RE, Willaert R, Solomon BD, Juusola J.

Genet Med. 2019 Sep;21(9):2036-2042. doi: 10.1038/s41436-019-0454-9. Epub 2019 Feb 11.

PMID:
30739909
30.

Promoting Bike Helmet Safety for Urban Children Through a Culturally Tailored Educational Video Intervention.

Ryan LM, Solomon BS, Ziegfeld S, Gielen A, Malloy L, Foster D, Smith KC, McDonald E.

Health Promot Pract. 2019 Jan 22:1524839918822271. doi: 10.1177/1524839918822271. [Epub ahead of print]

PMID:
30667272
31.

Radiotherapy and immunotherapy: a synergistic effect in cancer care.

Turgeon GA, Weickhardt A, Azad AA, Solomon B, Siva S.

Med J Aust. 2019 Jan;210(1):47-53. doi: 10.5694/mja2.12046. Epub 2018 Dec 12. Review.

PMID:
30636308
32.

Mother-child histocompatibility and risk of rheumatoid arthritis and systemic lupus erythematosus among mothers.

Cruz GI, Shao X, Quach H, Quach D, Ho KA, Sterba K, Noble JA, Patsopoulos NA, Busch MP, Triulzi DJ, Ladas N, Blasczyk R, Wong WSW, Solomon BD, Niederhuber JE, Criswell LA, Barcellos LF.

Genes Immun. 2019 Jan 12. doi: 10.1038/s41435-018-0055-7. [Epub ahead of print]

PMID:
30635658
33.

Dynamic Thromboembolic Risk Modelling to Target Appropriate Preventative Strategies for Patients with Non-Small Cell Lung Cancer.

Alexander M, Ball D, Solomon B, MacManus M, Manser R, Riedel B, Westerman D, Evans SM, Wolfe R, Burbury K.

Cancers (Basel). 2019 Jan 8;11(1). pii: E50. doi: 10.3390/cancers11010050.

34.

Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis.

Sutcliffe EG, Bartenbaker Thompson A, Stettner AR, Marshall ML, Roberts ME, Susswein LR, Wang Y, Klein RT, Hruska KS, Solomon BD.

Fam Cancer. 2019 Apr;18(2):203-209. doi: 10.1007/s10689-018-00116-2.

PMID:
30604180
35.

The etiology of VACTERL association: Current knowledge and hypotheses.

Solomon BD.

Am J Med Genet C Semin Med Genet. 2018 Dec;178(4):440-446. doi: 10.1002/ajmg.c.31664. Review.

PMID:
30580478
36.

The Refugee Health Partnership: A Longitudinal Experiential Medical Student Curriculum in Refugee/Asylee Health.

Bernhardt LJ, Lin S, Swegman C, Sellke R, Vu A, Solomon BS, Cuneo CN.

Acad Med. 2019 Apr;94(4):544-549. doi: 10.1097/ACM.0000000000002566.

PMID:
30570498
37.

Response to Evans et al.

Roberts ME, Zeinomar N, Solomon BD, Terry MB, Chung WK.

Genet Med. 2019 Aug;21(8):1880-1881. doi: 10.1038/s41436-018-0400-2. Epub 2018 Dec 19. No abstract available.

PMID:
30563985
38.

Cancer genetics program: Follow-up on clinical genetics and genomic medicine in Qatar.

Al-Bader SB, Alsulaiman R, Bugrein H, Ben Omran T, Abbaszadeh F, Bakheet N, Apsa Kusasi S, Abdou N, Solomon BD, Ghazouani H.

Mol Genet Genomic Med. 2018 Nov;6(6):865-872. doi: 10.1002/mgg3.534. Epub 2018 Dec 16. Review.

39.

Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.

Mitchell EL, Lau PKH, Khoo C, Liew D, Leung J, Liu B, Rischin A, Frauman AG, Kee D, Smith K, Brady B, Rischin D, Gibson A, Mileshkin L, Klein O, Weickhardt A, Arulananda S, Shackleton M, McArthur G, Östör A, Cebon J, Solomon B, Buchanan RR, Wicks IP, Lo S, Hicks RJ, Sandhu S.

Eur J Cancer. 2018 Dec;105:88-102. doi: 10.1016/j.ejca.2018.09.027. Epub 2018 Nov 13.

PMID:
30439628
40.

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study.

Solomon BJ, Besse B, Bauer TM, Felip E, Soo RA, Camidge DR, Chiari R, Bearz A, Lin CC, Gadgeel SM, Riely GJ, Tan EH, Seto T, James LP, Clancy JS, Abbattista A, Martini JF, Chen J, Peltz G, Thurm H, Ou SI, Shaw AT.

Lancet Oncol. 2018 Dec;19(12):1654-1667. doi: 10.1016/S1470-2045(18)30649-1. Epub 2018 Nov 6. Erratum in: Lancet Oncol. 2019 Jan;20(1):e10.

PMID:
30413378
41.

Germline pathogenic variants identified in women with ovarian tumors.

Carter NJ, Marshall ML, Susswein LR, Zorn KK, Hiraki S, Arvai KJ, Torene RI, McGill AK, Yackowski L, Murphy PD, Xu Z, Solomon BD, Klein RT, Hruska KS.

Gynecol Oncol. 2018 Dec;151(3):481-488. doi: 10.1016/j.ygyno.2018.09.030. Epub 2018 Oct 12.

PMID:
30322717
42.

Author Correction: Parent-of-origin-specific signatures of de novo mutations.

Goldmann JM, Wong WSW, Pinelli M, Farrah T, Bodian D, Stittrich AB, Glusman G, Vissers LELM, Hoischen A, Roach JC, Vockley JG, Veltman JA, Solomon BD, Gilissen C, Niederhuber JE.

Nat Genet. 2018 Nov;50(11):1615. doi: 10.1038/s41588-018-0226-5.

PMID:
30291356
43.

A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan Glycosylation.

Ferreira CR, Xia ZJ, Clément A, Parry DA, Davids M, Taylan F, Sharma P, Turgeon CT, Blanco-Sánchez B, Ng BG, Logan CV, Wolfe LA, Solomon BD, Cho MT, Douglas G, Carvalho DR, Bratke H, Haug MG, Phillips JB, Wegner J, Tiemeyer M, Aoki K; Undiagnosed Diseases Network; Scottish Genome Partnership, Nordgren A, Hammarsjö A, Duker AL, Rohena L, Hove HB, Ek J, Adams D, Tifft CJ, Onyekweli T, Weixel T, Macnamara E, Radtke K, Powis Z, Earl D, Gabriel M, Russi AHS, Brick L, Kozenko M, Tham E, Raymond KM, Phillips JA 3rd, Tiller GE, Wilson WG, Hamid R, Malicdan MCV, Nishimura G, Grigelioniene G, Jackson A, Westerfield M, Bober MB, Gahl WA, Freeze HH.

Am J Hum Genet. 2018 Oct 4;103(4):553-567. doi: 10.1016/j.ajhg.2018.09.003.

44.

Basan gets a new fingerprint: Mutations in the skin-specific isoform of SMARCAD1 cause ectodermal dysplasia syndromes with adermatoglyphia.

Valentin MN, Solomon BD, Richard G, Ferreira CR, Kirkorian AY.

Am J Med Genet A. 2018 Nov;176(11):2451-2455. doi: 10.1002/ajmg.a.40485. Epub 2018 Oct 5.

PMID:
30289605
45.

Magnetic resonance-guided focused ultrasound thalamotomy for treatment of essential tremor: A 2-year outcome study.

Meng Y, Solomon B, Boutet A, Llinas M, Scantlebury N, Huang Y, Hynynen K, Hamani C, Fasano A, Lozano AM, Lipsman N, Schwartz ML.

Mov Disord. 2018 Oct;33(10):1647-1650. doi: 10.1002/mds.99. Epub 2018 Oct 4.

PMID:
30288794
46.

Osteomyelitis as a Result of Pancreaticojejunostomy Stent Migration after Whipple Procedure.

Munis A, Solomon B, Mazulis A, Laurie T.

ACG Case Rep J. 2018 Sep 26;5:e67. doi: 10.14309/crj.2018.67. eCollection 2018.

47.

Clinical genetics and genomic medicine in Qatar.

Al-Dewik N, Al-Mureikhi M, Shahbeck N, Ali R, Al-Mesaifri F, Mahmoud L, Othman A, AlMulla M, Sulaiman RA, Musa S, Abdoh G, El-Akouri K, Solomon BD, Ben-Omran T.

Mol Genet Genomic Med. 2018 Sep;6(5):702-712. doi: 10.1002/mgg3.474. No abstract available.

48.

Mind the Graph: Foregone Health Gains in Lung Cancer.

Cameron L, Sullivan R, Luey B, Solomon B.

Semin Oncol. 2018 Oct;45(5-6):316-317. doi: 10.1053/j.seminoncol.2017.11.004. Epub 2017 Dec 6. No abstract available.

PMID:
30262394
49.

Alectinib as first-line therapy for ALK-rearranged NSCLC: a no-brainer?

Thai AA, Solomon BJ.

Ann Oncol. 2018 Nov 1;29(11):2160-2162. doi: 10.1093/annonc/mdy415. No abstract available.

PMID:
30239586
50.

TIGIT: a novel immunotherapy target moving from bench to bedside.

Solomon BL, Garrido-Laguna I.

Cancer Immunol Immunother. 2018 Nov;67(11):1659-1667. doi: 10.1007/s00262-018-2246-5. Epub 2018 Sep 19. Review.

PMID:
30232519

Supplemental Content

Loading ...
Support Center